Mitsubishi Tanabe Pharma Generic Subsidiary Launches Six New Drugs
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma subsidiary Tanabe Seiyaku Hanbai launched six new generic drugs in Japan: H2 blocker cimetidine 400mg; angiotensin converting enzyme inhibitor temocapril 1mg, 2mg, 4mg; hypertension drug doxazosin 0.5mg, 1mg, 2mg and 4mg; gastric drug sofalcone 20 percent granule; cefinidir capsule 50 mg, 100mg; antibacterial levafloxacin 100 and 10 percent granule. (Click here for more - Japanese language